Vertebral Algic Syndrome Treatment in Long COVID—Cases Reports
Abstract
:1. Introduction
2. Materials and Methods
3. Cases Report
3.1. Patient 1
3.2. Patient 2
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Greenhalgh, T.; Knight, M.; Court, C. Management of post-acute covid-19 in primary care. BMJ 2020, 370, 3026. [Google Scholar] [CrossRef] [PubMed]
- Chen, X.; Zheng, F. Epidemiological and Clinical Features of 291 Cases with Coronavirus Disease 2019 in Areas Adjacent to Hubei, China: A Double-Center Observational Study. Available online: https://www.medrxiv.org/content/10.1101/2020.03.03.20030353v1 (accessed on 3 May 2021).
- Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available online: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (accessed on 25 February 2021).
- Weng, L.; Su, X.; Wang, X. Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review. J. Pain Res. 2021, 14, 147–159. [Google Scholar] [CrossRef] [PubMed]
- Murat, S.; Dogruoz Karatekin, B. Clinical presentations of pain in patients with COVID-19 infection. Ir. J. Med. Sci. 2021, 190, 913–917. [Google Scholar] [CrossRef] [PubMed]
- Cipollaro, L.; Giordano, L. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J. Orthop. Surg. Res. 2020, 15, 178–185. [Google Scholar] [CrossRef]
- Giacomelli, A.; Pezzati, L. Self-reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin. Infect. Dis. 2020, 7, 889–890. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Aksan, F.; Nelson, E.A.; Swedish, K.A. A COVID-19 patient with intense burning pain. J. Neurovirol. 2020, 26, 800–801. [Google Scholar] [CrossRef]
- Davis, K. COVID-19 pneumonia with back pain: Presentation of an acute pulmonary embolism associated with novel coronavirus infection in an outpatient setting. Clin. Case Rep. 2020, 8, 2514–2517. [Google Scholar] [CrossRef]
- Marzano, A.V.; Cassano, N.; Genovese, G. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue. Br. J. Dermatol. 2020, 183, 431–442. [Google Scholar] [CrossRef]
- Wu, Y.; Xu, X.; Chen, Z. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020, 87, 18–22. [Google Scholar] [CrossRef]
- Chochol, J.; Džubera, A.; Illéš, R.; Chocholová, A.; Zemková, E. Vertebral Pain in Acute COVID-19—Cases Report. Appl. Sci. 2021, 11, 6926. [Google Scholar] [CrossRef]
- Raveendran, A.V.; Jayadevan, R.; Sashidharan, S. Long COVID: An overview. Diabetes Metab. Syndr. 2021, 15, 869–875. [Google Scholar] [CrossRef] [PubMed]
- Lopez-Leon, S.; Wegman-Ostrosky, T.; Perelman, C. More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021, 11, 16144. [Google Scholar] [CrossRef]
- Crook, H.; Raza, S.; Nowell, J. Long covid—Mechanisms, risk factors, and management. BMJ 2021, 374, 1648. [Google Scholar] [CrossRef] [PubMed]
- Raveendran, A.V. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab. Syndr. 2021, 15, 145–146. [Google Scholar] [CrossRef]
- Garg, P.; Arora, U.; Kumar, A. The “post-COVID” syndrome: How deep is the damage? J. Med. Virol. 2021, 93, 673–674. [Google Scholar] [CrossRef]
- Tenforde, M.W.; Kim, S.S.; Lindsell, C.J. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network—United States, March–June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 993–998. [Google Scholar] [CrossRef]
- Kamal, M.; Abo Omirah, M.; Hussein, A. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2021, 75, e13746. [Google Scholar] [CrossRef]
- Hussman, J.P. Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention. Front. Pharmacol. 2020, 11, 1169–1186. [Google Scholar] [CrossRef]
- Carfì, A.; Bernabei, R.; Landi, F.; Gemelli against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020, 324, 603–605. [Google Scholar] [CrossRef]
- Huang, Y.; Pinto, M.D.; Borelli, J.L. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. medRxiv 2021. [Google Scholar] [CrossRef]
- Ladds, E.; Rushforth, A.; Wieringa, S. Persistent symptoms after Covid-19: Qualitative study of 114 “long Covid” patients and draft quality principles for services. BMC Health Serv. Res. 2020, 20, 1144. [Google Scholar] [CrossRef]
- Dennis, A.; Wamil, M.; Kapur, S.; Alberts, J.; Badley, A.D.; Decker, G.A.; Rizza, S.A.; Banerjee, R.; Banerjee, A. Multi-organ impairment in low-risk individuals with long COVID. MedRxiv 2020. [Google Scholar] [CrossRef]
- Guan, W.J.; Ni, Z.Y. China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020, 382, 1708–1720. [Google Scholar] [CrossRef] [PubMed]
- Şahin, T.; Ayyildiz, A. Pain Symptoms in COVID-19. Am. J. Phys. Med. Rehabil. 2021, 100, 307–312. [Google Scholar] [CrossRef] [PubMed]
- Olafsson, G.; Jonsson, E. Cost of low back pain: Results from a national register study in Sweden. Eur. Spine J. 2018, 27, 2875–2881. [Google Scholar] [CrossRef] [Green Version]
- Dutmer, A.L.; Schiphorst Preuper, H.R. Personal and Societal Impact of Low Back Pain. The Groningen Spine Cohort. Spine 2019, 44, E1443–E1451. [Google Scholar] [CrossRef]
- Battié, M.; Videman, T. Lumbar Disc Degeneration: Epidemiology and Genetic Influences. Spine 2004, 29, 2679–2690. [Google Scholar] [CrossRef] [Green Version]
- Šagát, P.; Bartík, P.; Prieto González, P. Impact of COVID-19 Quarantine on Low Back Pain Intensity, Prevalence, and Associated Risk Factors among Adult Citizens Residing in Riyadh (Saudi Arabia): A Cross-Sectional Study. Int. J. Environ. Res. Public Health 2020, 17, 7302. [Google Scholar] [CrossRef]
- Xiong, Q.; Xu, M.; Li, J.; Liu, Y.; Zhang, J.; Xu, Y.; Dong, W. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021, 27, 89–95. [Google Scholar] [CrossRef]
- Carvalho-Schneider, C.; Laurent, E.; Lemaignen, A. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021, 27, 258–263. [Google Scholar] [CrossRef]
- Helms, J.; Kremer, S.; Merdji, H. Neurologic features in severe SARSCoV-2 infection. N. Engl. J. Med. 2020, 382, 2268–2270. [Google Scholar] [CrossRef] [PubMed]
- Savarraj, J.P.J.; Burkett, A.B.; Hinds, S.N. Three-month outcomes in hospitalized COVID-19 patients. MedRxiv 2020. [Google Scholar] [CrossRef]
- Mao, L.; Jin, H.; Wang, M. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020, 77, 683–690. [Google Scholar] [CrossRef] [Green Version]
- Koralnik, I.J.; Tyler, K.L. COVID-19: A Global Threat to the Nervous System. Ann. Neurol. 2020, 88, 1–11. [Google Scholar] [CrossRef]
- Zubair, A.S.; McAlpine, L.S.; Gardin, T. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020, 77, 1018–1027. [Google Scholar] [CrossRef] [PubMed]
- Desforges, M.; Le Coupanec, A.; Dubeau, P. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses 2019, 12, 14. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. COVID-19 Clinical Management: Living Guidance. 2021. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1 (accessed on 8 August 2021).
- National Institute of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. 2021. Available online: https://www.covid19treatmentguidelines.nih.gov/ (accessed on 8 August 2021).
- National Institute of Health. Therapeutic Management of Hospitalized Adults with COVID-19. Available online: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/hospitalized-adults--therapeutic-management/ (accessed on 8 August 2021).
- Centers for Disease Control and Prevention. Clinical Care Information for COVID-19. Available online: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care.html (accessed on 8 August 2021).
- Crichton, N. Visual analogue scale (VAS). J. Clin. Nurs. 2001, 10, 697–706. [Google Scholar]
- Booth, F.W.; Lees, S.J. Physically active subjects should be the control group. Med. Sci. Sports Exerc. 2006, 38, 405–406. [Google Scholar] [CrossRef]
Patient | Gender | Age (Years) | Pre-COVID-19 VAS | Peri-COVID-19 VAS | Post-COVID-19 VAS | Post-Surgery VAS |
---|---|---|---|---|---|---|
1 | F | 51 | 1 | 9 | 8 | 0 |
2 | M | 52 | 3 | 7 | 5 | 1 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Džubera, A.; Chochol, J.; Illéš, R.; Chocholová, A.; Zemková, E. Vertebral Algic Syndrome Treatment in Long COVID—Cases Reports. Int. J. Environ. Res. Public Health 2021, 18, 11457. https://doi.org/10.3390/ijerph182111457
Džubera A, Chochol J, Illéš R, Chocholová A, Zemková E. Vertebral Algic Syndrome Treatment in Long COVID—Cases Reports. International Journal of Environmental Research and Public Health. 2021; 18(21):11457. https://doi.org/10.3390/ijerph182111457
Chicago/Turabian StyleDžubera, Andrej, Juraj Chochol, Róbert Illéš, Alica Chocholová, and Erika Zemková. 2021. "Vertebral Algic Syndrome Treatment in Long COVID—Cases Reports" International Journal of Environmental Research and Public Health 18, no. 21: 11457. https://doi.org/10.3390/ijerph182111457
APA StyleDžubera, A., Chochol, J., Illéš, R., Chocholová, A., & Zemková, E. (2021). Vertebral Algic Syndrome Treatment in Long COVID—Cases Reports. International Journal of Environmental Research and Public Health, 18(21), 11457. https://doi.org/10.3390/ijerph182111457